Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
Key facts
- Who runs it
- University of Central Florida
- Where
- Orlando, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 11 people enrolled
- Started
- 19 Mar 2025
- Ended
- 30 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nonspecific Hypnotherapy for Relaxation
- Gut-Directed Hypnotherapy (GDH)
- 3-month Follow-Up
- Record updated
- 4 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- 18 years or older
- Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction
- English speaking
- Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys
Who cannot take part
- Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders)
- Under 18 years
- Pregnant women
- Prisoners
- Children
- A hypnotic susceptibility score in the low range (SHSS; total = 0-3)
Where in United States
- University of Central FloridaOrlando, United States
About the trial
What the trial wants to find out
This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
The 2 groups in the trial
- Group 1Existing treatment, for comparison
Total enrollment time in the study will be 4 months. Participants will be divided into two groups of ten, and treatment will be provided in two 14-day intervention phases with one 3-month follow-up . One phase will include nonspecific hypnotherapy for relaxation, and one phase will include Gut-Directed Hypnotherapy (GDH) presented in a counterbalanced order depending on random assignment. Treatment conditions will be presented in a counterbalanced order depending on random assignment Hypnotherapy sessions will take place via Zoom sessions. There will be 4 sessions within each fourteen-day phase. Outcomes will be assessed through pre- and post-phase surveys, along with pre-and post-session surveys and one 3-month follow-up after completion of the two intervention phases.
Treatment: Nonspecific Hypnotherapy for Relaxation, Gut-Directed Hypnotherapy (GDH), and 3-month Follow-Up
- Group 2Existing treatment, for comparison
Total enrollment time in the study will be 4 months. Participants will be divided into two groups of ten, and treatment will be provided in two 14-day intervention phases with one 3-month follow-up . One phase will include nonspecific hypnotherapy for relaxation, and one phase will include Gut-Directed Hypnotherapy (GDH) presented in a counterbalanced order depending on random assignment. Treatment conditions will be presented in a counterbalanced order depending on random assignment Hypnotherapy sessions will take place via Zoom sessions. There will be 4 sessions within each fourteen-day phase. Outcomes will be assessed through pre- and post-phase surveys, along with pre-and post-session surveys and one 3-month follow-up after completion of the two intervention phases.
Treatment: Nonspecific Hypnotherapy for Relaxation, Gut-Directed Hypnotherapy (GDH), and 3-month Follow-Up
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Use of Telehealth-Delivered Gut-Directed Hypnotherapy for Managing Gastrointestinal Health
- Record updated
- 4 November 2025